Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Equity Income (2016 - 2025)

Historic Equity Income for Fresenius Medical Care AG (FMS) over the last 16 years, with Q3 2025 value amounting to -$54.6 million.

  • Fresenius Medical Care AG's Equity Income fell 2044.79% to -$54.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.4 million, marking a year-over-year decrease of 3944.63%. This contributed to the annual value of -$144.3 million for FY2024, which is 990.04% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Equity Income stood at -$54.6 million, which was down 2044.79% from -$51.1 million recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Equity Income peaked at -$11.8 million during Q1 2022, and registered a low of -$54.6 million during Q3 2025.
  • Over the past 5 years, Fresenius Medical Care AG's median Equity Income value was -$29.5 million (recorded in 2023), while the average stood at -$32.2 million.
  • Its Equity Income has fluctuated over the past 5 years, first tumbled by 52778.21% in 2021, then surged by 6484.51% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Equity Income (Quarter) stood at -$24.0 million in 2021, then rose by 19.31% to -$19.4 million in 2022, then decreased by 27.66% to -$24.7 million in 2023, then tumbled by 38.18% to -$34.2 million in 2024, then tumbled by 59.56% to -$54.6 million in 2025.
  • Its last three reported values are -$54.6 million in Q3 2025, -$51.1 million for Q2 2025, and -$50.5 million during Q1 2025.